title: Bleeding risk and incidence in real world percutaneous coronary intervention patients with ticagrelor.
authors.affiliation: The Northern Hospital, Cardiology Department, Epping, Victoria, Australia. Electronic address: ivansubiakto@gmail.com.
authors.forename: Ivan
authors.initials: I
authors.lastname: Subiakto
authors.affiliation: The Northern Hospital, Cardiology Department, Epping, Victoria, Australia; University of Melbourne, Parkville, Australia.
authors.forename: Muhammad
authors.initials: M
authors.lastname: Asrar ul Haq
authors.affiliation: The Northern Hospital, Cardiology Department, Epping, Victoria, Australia; University of Melbourne, Parkville, Australia.
authors.forename: William J
authors.initials: WJ
authors.lastname: Van Gaal
mesh_terms: D000241:Adenosine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000368:Aged; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D062645:Percutaneous Coronary Intervention; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D000077486:Ticagrelor
chemical_list: D058921:Purinergic P2Y Receptor Antagonists; D000077486:Ticagrelor; D000241:Adenosine
keywords: Acute Coronary Syndrome; Bleeding; Dyspnoea; Female; Ticagrelor